Xu; Fuming
Patent Applications and Registrations
Patent applications and USPTO patent grants for Xu; Fuming.The latest application filed is for "estrogen receptor protein degraders".
- Xu; Fuming - Shanghai CN
- Xu; Fuming - Ann Arbor MI
- Xu; Fuming - Ypsilanti MI
- XU; Fuming - Shanghai City CN
| Patent | Date |
|---|---|
| Dental implant distractor Grant 11,337,782 - Zhang , et al. May 24, 2 | 2022-05-24 |
| Estrogen Receptor Protein Degraders App 20220079931 - Wang; Shaomeng ; et al. | 2022-03-17 |
| BET bromodomain protein degraders with cleavable linkers Grant 11,267,822 - Wang , et al. March 8, 2 | 2022-03-08 |
| MDM2 protein degraders Grant 11,192,898 - Wang , et al. December 7, 2 | 2021-12-07 |
| Small Molecule Menin Inhibitors App 20210353610 - WANG; Shaomeng ; et al. | 2021-11-18 |
| Dental Implant Distractor App 20210322137 - ZHANG; Chenping ; et al. | 2021-10-21 |
| Fused 1,4-oxazepines As Bet Protein Degraders App 20210284657 - Wang; Shaomeng ; et al. | 2021-09-16 |
| Fused 1,4-diazepines as BET bromodomain inhibitors Grant 11,046,709 - Wang , et al. June 29, 2 | 2021-06-29 |
| Fused 1,4-diazepines as BET protein degraders Grant 10,975,093 - Wang , et al. April 13, 2 | 2021-04-13 |
| Monofunctional Intermediates For Ligand-dependent Target Protein Degradation App 20210002289 - Li; Yangbing ; et al. | 2021-01-07 |
| BET Bromodomain Protein Degraders with Cleavable Linkers App 20200277305 - Wang; Shaomeng ; et al. | 2020-09-03 |
| Monofunctional intermediates for ligand-dependent target protein degradation Grant 10,759,808 - Wang , et al. Sep | 2020-09-01 |
| BET protein degraders Grant 10,633,386 - Wang , et al. | 2020-04-28 |
| Fused 1,4-Diazepines as BET Bromodomain Inhibitors App 20190382415 - Wang; Shaomeng ; et al. | 2019-12-19 |
| Fused 1,4-diazepines As Bet Protein Degraders App 20190263827 - Wang; Shaomeng ; et al. | 2019-08-29 |
| Bet Protein Degraders App 20190169195 - Wang; Shaomeng ; et al. | 2019-06-06 |
| Mdm2 Protein Degraders App 20190127387 - Wang; Shaomeng ; et al. | 2019-05-02 |
| Monofunctional Intermediates For Ligand-dependent Target Protein Degradation App 20190119289 - Wang; Shaomeng ; et al. | 2019-04-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 